What is changing in the rules, what it means for your product, your municipality or your project, and who here handles it. In English and Portuguese.
Our monitoring reports record the changes to cosmetics rules in a given period, and we publish one each month. Each one is a dated publication: it reflects the rules on the date it was published and is not updated afterwards. For what applies today, read the latest briefings or ask us.
Ingredients: ALUMINIUM
Date of publication: 14/12/2023
On December 14 2023, the Scientific Committee on Consumer Safety (SCCS) published the Preliminay Opinion on the use of aluminium in cosmetic products. The deadline for comments is set to February 16, 2024.
Ingredients: MICROPLASTICS
Date of publication: 27/09/2023
On 27 September, 2023, the European Commission published Regulation (EU) 2023/2055 which introduces stricter restrictions on products that contain intentionally-added microplastics, including cosmetics.
Ingredients: Kojic Acid
The UK's Scientific Advisory Group on Chemical Safety in Consumer Products (SAG-CS) published its final opinion on Kojic Acid as used in cosmetic products.
Ingredients: BHT
The UK's Scientific Advisory Group on Chemical Safety in Consumer Products (SAG-CS) published its final opinion on BHT as used in cosmetic products.
Ingredients: METHYL SALICYLATE
Date of publication: 14/09/2023
On 14 September, 2023, the Scientific Committee on Consumer Safety (SCCS) published its Final Opinion on the safety of Methyl Salicylate as used in cosmetic products intended to children.
The European Commission published Regulation 2023/1545, amending The EU Cosmetics Regulation by adding new allergens to be declared on the ingredient list of the label of cosmetic products. The new amendment will add 56 new substances to the allergens list, and these substances must be declared when present at certain concentrations in cosmetic products.
On 20 July 2023, the European Commission published the CMR Omnibus VI Regulation (EU) 2023/1490. This regulation prohibits the substances classified as Carcinogenic, Mutagenic and Toxic to Reproduction (CMR) 1A, 1B, or 2 by the 18th Adaptation to Technical Progress (ATP) to the EU Classification Labelling and Packaging (CLP) Regulation. The regulation enters into force on the 1st of December 2023.
On 15 August 2023, the Office for Product Safety and Standards (OPSS – the UK regulator for cosmetic products) issued calls for data on the safety of cosmetic ingredients to investigate any suspected endocrine disrupting properties and safety whe used as nanomaterials.
Update of Commission Decision (EU) 2021/1870 which establishes EU Ecolabel criteria and related assessment and verifications requirements for cosmetic products.
The French National Agency for Food, Environmental and Occupational Health Safety (ANSES) has sent the French government a request to ban the use of the UV filter Octocrylene in sunscreen products.
Ingredient: CYCLAMEN ALDEHYDE
Date of publication: 8 June 2026
The Scientific Committee on Consumer Safety (SCCS) has accepted a mandate to assess the safety of Cyclamen Aldehyde, following potential classification as a reproductive toxicant under the CLP Regulation.
Topic: OMNIBUS ACT IX - COSMETICS REGULATION
Date of publication: 28 July 2026
The European Commission notified the WTO about the draft Omnibus Act IX, proposing amendments to Annexes II, III, and V of the EU Cosmetics Regulation.
Topic: NEW RESTRICTIONS ON COSMETIC INGREDIENTS
Date of publication: 13 January 2026
The European Commission published Commission Regulation (EU) 2026/78, which brings new restrictions on several cosmetic ingredients that were classified as Carcinogenic, Mutagenic or Toxic for Reproduction (CMR).
Ingredient: TALC
Date of publication: January 2026
The United Kingdom (UK) Health and Safety Executive (HSE) has published a technical report concluding that Talc does not warrant carcinogenicity classification, diverging from ECHA's Risk Assessment Committee (RAC) opinion supporting Category 1B classification.
Four EUDAMED modules have been mandatory since 28 May 2026. Devices already on the market have until 27 November 2026. Who registers what, and what changed in Portugal.
From 25 February 2027, notified bodies under the MDR and IVDR must quote on defined information, keep to maximum timelines and publish their performance. What it changes for manufacturers.
Whether software is a medical device depends on what you say it is for, not on the code. The qualification test under the MDR and IVDR, updated for 2025 guidance.
Clinical data from an equivalent device can support your clinical evaluation, but the MDR sets a higher bar than the Directives did. The three characteristics, data access, and documentation.
One email when an area publishes, in the language you choose. Nothing else.
